Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID [Phase 1]
A Phase 1 proof-of-concept study evaluating the immunogenicity and safety of a Hepatitis B vaccine delivered in the dermis using VAX-ID, spo…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine [Phase 3]
This clinical trial update describes a Phase 3 exploratory study of hepatitis B virus kinetics during telbivudine treatment. The study statu…
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years [Phase 3]
Phase 3 trial comparing an adjuvanted Hepatitis B vaccine to a double dose of Engerix-B in adults on pre-dialysis or haemodialysis, aged 15 …
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054) [Phase 3]
Phase 3 clinical trial updating safety, tolerability, and immunogenicity of a recombinant Hepatitis B vaccine with an upgraded production pr…
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056) [Phase 2]
Phase 2 trial update reporting completion of a study on a modified-process Hepatitis B vaccine in healthy neonates.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver [Phase 1, Phase 2]
Phase 1/2 trial investigating adefovir plus vaccination in liver transplant recipients without Hepatitis B who are core antibody positive; s…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults [Phase 4]
This Phase 4 study reports that the combined Hepatitis A and B vaccine is non-inferior to monovalent vaccines in adults.
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants [Phase 3]
Phase 3 clinical trial update assessing immune memory and reactogenicity of the DTPw-HBV/Hib pentavalent vaccine in infants, including respo…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025
A completed substudy within the ATN 024/025 trials examining genetic factors related to the Hepatitis B vaccine in individuals with HIV infe…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B [Phase 3]
A Phase 3 clinical trial comparing switching from lamivudine to telbivudine versus continuing lamivudine in adults with chronic hepatitis B …
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B [Phase 4]
Phase 4 trial evaluating the efficacy and safety of telbivudine 600 mg tablets in Chinese patients with chronic hepatitis B completed.
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of Pegasys for chronic hepatitis B has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers [Phase 1]
Phase 1 safety and pharmacokinetic study of Hepalatide (L47) in healthy volunteers has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine [Phase 2]
This Phase 2 trial evaluated the feasibility of administering an acellular pertussis vaccine soon after birth, followed by a 3-dose primary …
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: A Study of Peginterferon Alfa-2a in Participants With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program [Phase 4]
Phase 4 expanded-access study of peginterferon alfa-2a in chronic hepatitis B has completed and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Off-therapy Response After Stopping Entecavir or Tenofovir
A clinical trial assessing the off-therapy response after stopping entecavir or tenofovir in chronic hepatitis B patients; current status is…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial
A clinical trial update reports the durability of antiviral activity in chronic hepatitis B patients who achieved complete response in the L…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV [Phase 3]
Phase 3 study of clevudine 30 mg once daily in HBeAg-negative chronic hepatitis B was terminated.
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201 [Phase 2]
A Phase 2 safety and efficacy study of retreatment with clevudine in chronic hepatitis B patients who previously received clevudine in L-FMA…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials [Phase 3]
Phase 3 safety and antiviral activity update for Clevudine in Hepatitis B patients who completed L-FMAU-301 or L-FMAU-302; the trial has bee…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV [Phase 3]
Phase 3 safety and antiviral activity study of clevudine 30 mg once daily in patients with chronic hepatitis B. The trial status is terminat…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Ultrasound Method to Measure Fibrosis of the Liver in Children [NA]
Update on a pediatric ultrasound method to measure liver fibrosis; the trial was terminated and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV [NA]
The UCLA-sponsored trial evaluating prevention strategies for Hepatitis B among homeless individuals at risk for HBV, Hepatitis C, and HIV h…
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B [Phase 3]
A Phase 3 trial comparing telbivudine and entecavir in HBeAg-positive chronic hepatitis B completed, evaluating reduction of serum HBsAg lev…
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis B [Phase 2]
Phase 2 trial evaluating a combination of peginterferon alfa-2b and GM-CSF for chronic hepatitis B has completed.